Clik here to view.
Maralixibat Chloride, ماراليكسيبات كلوريد , 氯马昔巴特 , Мараликсибата хлорид
Maralixibat chloride Maralixibat Chloride, ماراليكسيبات كلوريد , 氯马昔巴特 , Мараликсибата хлорид SHP625, Maralixibat chloride, Molecular Formula C40-H56-N3-O4-S.Cl, Molecular Weight, 710.4184...
View ArticleClik here to view.
GSK 1070916 For Advanced solid tumor
GSK 1070916 NMI-900 , GSK-1070916, GSK-1070916A 4-[3-(4-N,N-Dimethylcarbamylaminophenyl)-1-ethyl-1H-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1H-pyrrolo[2,3-b]pyridine...
View ArticleClik here to view.
AMG 900, An aurora kinase (ARK) inhibitor potentially for the treatment of...
AMG-900 N-(4-((3-(2-aminopyrimidin-4-yl)pyridin-2-yl)oxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine....
View ArticleClik here to view.
Amneal Pharma’s, 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing...
Cas 1580464-40-9 MW458.97, C24 H19 Cl N6 S, 1H-Pyrazolo[3,4-d]pyrimidin-6-amine, 4-(4-chlorophenyl)-4,7-dihydro-3-methyl-1-(10H-phenothiazin-2-yl)-...
View ArticleClik here to view.
Recilisib Sodium, EX-RAD
Recilisib Sodium Phase I C16H12ClNaO4S Molecular Weight: 358.771849 g/mol A protein kinase inhibitor potentially for the treatment of acute radiation syndrome....
View ArticleClik here to view.
Indian API Manufacturers remain in the Focus of European GMP Inspectors
DRUG REGULATORY AFFAIRS INTERNATIONAL Some time ago three Non-Compliance Reports have been published in quick succession in the EudraGMDP database. Those reports deal with inspections performed at...
View ArticleClik here to view.
Revision of the general Chapter on Pharmaceutical Water in the US Pharmacopoeia
DRUG REGULATORY AFFAIRS INTERNATIONAL The 2nd supplement of USP39 NF34 comprises the revised version of the chapter on pharmaceutical water of the US Pharmacopoeia <1231> Water for...
View ArticleClik here to view.
Final WHO Guidance Document on Good Data and Record Management Practices
DRUG REGULATORY AFFAIRS INTERNATIONAL The WHO has just released the the final version of the important guideline “Good Data and Record Management Practices“....
View ArticleClik here to view.
Therapeutic Effect of Amaranthus hybridus on Diabetic Nephropathy
Diabetes Nephropathy, a chronic metabolic complication of diabetes mellitus, is characterized by elevated levels of serum glucose,creatinine, urea and uric acid in addition to abnormal...
View ArticleClik here to view.
Novartis, Torrent drug for diabetes, NVP-LBX192, LBX-192
(R)-3-Cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(4-methyl-piperazine-1-sulfonyl)-phenyl]-propionamide...
View ArticleClik here to view.
(±)-Integrifolin, Compound from plants keeps human cancer cells from multipying
CAS 89647-87-0 MFC15 H18 O4, MW 262.30 Azuleno[4,5-b]furan-2(3H)-one, decahydro-4,8-dihydroxy-3,6,9-tris(methylene)-, (3aR,4R,6aR,8S,9aR,9bR)- Azuleno[4,5-b]furan-2(3H)-one,...
View ArticleClik here to view.
UCT Drug Discovery and Development Centre, H3D, pioneers world-class drug...
UCT’s H3D is a center of excellence for research and innovation with an already strong track record in malaria drug discovery. The vision of H3D is to be the leading organization for integrated drug...
View ArticleClik here to view.
Roxadustat
ROXADUSTAT ASP1517; ASP 1517; ASP-1517; FG-4592; FG 4592; FG4592; Roxadustat. Fibrogen, Inc. CAS 808118-40-3 Chemical Formula: C19H16N2O5 Exact Mass: 352.10592 THERAPEUTIC CLAIM Treatment of anemia...
View ArticleClik here to view.
FDA approves first MRI-guided focused ultrasound device to treat essential...
Exablate Neuro – non-invasive, image-guided alternative for deep brain lesioning FDA approves first MRI-guided focused ultrasound device to treat essential tremor 07/11/2016 11:28 AM EDT The U.S....
View ArticleClik here to view.
Besifloxacin hydrochloride (Besivance)
Besifloxacin SS 734, BOL 303224A, ISV-403 MW 430.301, MF C19H21ClFN3O3 141388-76-3 CAS 7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid...
View ArticleClik here to view.
EMA reviews Medicines manufactured at U.S. Company
DRUG REGULATORY AFFAIRS INTERNATIONAL Following the issuance of two Non-Compliance Reports for two sites of the US based company, EMA has started a review of medicines manufactured by Pharmaceutics...
View ArticleClik here to view.
Drafts of revised USP plastic packaging chapters and : removal of the...
DRUG REGULATORY AFFAIRS INTERNATIONAL In a recent Pharmacopeial Forum two revised USP general chapters have been published for comment. With these drafts, the USP expert committee is removing the...
View ArticleClik here to view.
EDQM announces revision of general chapter Monocyte Activation Test (2.6.30)
DRUG REGULATORY AFFAIRS INTERNATIONAL On 23 June, the EDQM in Strasbourg announced the revision of the pharmacopoeial general chapter 2.6.30 on Monocyte Activation Test. see...
View ArticleClik here to view.
NEW PATENT, WO 2016108172, OSPEMIFENE AND FISPEMIFENE, OLON S.P.A.
Ospemifene is useful for treating menopause-induced vulvar and vaginal atrophy; while fispemifene is useful for treating symptoms related with male androgen deficiency and male neurological disorders....
View ArticleClik here to view.
Cipla to invest in South Africa’s first biosimilars production facility
Cipla to invest in South Africa’s first biosimilars production facility Indian-based pharmaceutical and biotechnology company Cipla will invest more than R1.3bn ($19.34m) in the first advanced biotech...
View Article